Skip to main content
Caplight Logo









Ousia Pharma

Ousia Pharma

Private
CopenhagenHealthcare & Life Scienceshttps://www.ousiapharma.com/

Last Round

Seed

May 6, 2025

Total Funding Raised

$17.15M

Company Overview

Ousia Pharma is a biotechnology company that develops innovative peptide-drug conjugates for the treatment of obesity and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologypeptide-drug conjugatesobesity treatmentcardiometabolic diseasedrug discoveryGLP-1NMDA receptor antagonistweight loss drugclinical-stage biotechbiopharmatherapeutic developmentobesity medicinelicensing agreementpreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ousia Pharma Comparables

Compare Ousia Pharma with similar companies based on industry and business-model similarity.

Ousia Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Roche Holding
70%
Zealand Pharma
69%
Novo Nordisk
68%

Ousia Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 6, 2025
Pre SeedMar 17, 2023

Key People

Founding team and executive leadership

Jonas Odgaard Petersen

Co-founder, Chief Operating Officer

Founding Team

Ousia Pharma Investors

Notable investors and investment history

Ousia Pharma investors
InvestorRounds
Omega FundsSeed
BioInnovation InstitutePre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 565% MoM.

  • Sep 4, 2025

    Grew 100% QoQ from 4 to 8 employees.

Ousia Pharma Filings

Explore SEC and related filing metadata, where available.

Ousia Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ousia Pharma's valuation, stock price, and market status.

Is Ousia Pharma a public or private company?

Ousia Pharma is a private company.

What is the current stock price of Ousia Pharma?

Ousia Pharma is a private company with no public stock price. No recent secondary market data is available.

How much is Ousia Pharma worth (valuation)?

Valuation information for Ousia Pharma is not publicly available.

Can I buy Ousia Pharma stock?

Ousia Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ousia Pharma's last funding round?

Ousia Pharma's most recent funding round was Seed on May 6, 2025.

Who are the main investors in Ousia Pharma?

Key investors in Ousia Pharma include Omega Funds.

Will Ousia Pharma IPO soon?

No public IPO plans have been announced for Ousia Pharma.

How can I track Ousia Pharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ousia Pharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Employee Range5
Year Founded2022
Last FundingMay 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?